Nutritional and metabolic status of HIV-positive patients with lipodystrophy during one year of follow-up

Nutritional and metabolic status of HIV-positive patients with lipodystrophy during one year of follow-up

OBJECTIVES: The aim of this prospective study was to compare changes in lipid metabolism and nutritional status after either 6 and 12 months of follow-up in subjects with lipodystrophy syndrome after traditional lifestyle therapy with or without fibric acid analogue intervention (bezafibrate and clo...

Full description

Bibliographic Details
Main Authors:	Eloísa Marchi dos Anjos, Karina Pfrimer, Alcyone Artioli Machado, Selma Freire de Carvalho Cunha, Roberta Garcia Salomão, Jacqueline Pontes Monteiro
Format:	Article
Language:	English
Published:	Faculdade de Medicina / USP 2011-01-01
Series:	Clinics
Subjects:	HIV-Positive Patients Dyslipidemia Nutritional Assessment Lipid Metabolism Fibrate
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000300007

Similar Items

Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis
by: Satoshi Ida, et al.
Published: (2019-03-01)

Hypolipemiant Treatment: Making the Right Choice for Osteoporotic Patients
by: Șipoș Remus, et al.
Published: (2013-02-01)

Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs
by: Donatella Zodda, et al.
Published: (2018-01-01)

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits
by: Cristóbal Flores-Castillo, et al.
Published: (2019-05-01)

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
by: Tenenbaum Alexander, et al.
Published: (2004-12-01)

Medical Compliance of Fibrate and the Decreased Risk of Age-Related Macular Degeneration in Dyslipidemia-Related Diseases: A Population-Based Cohort Study
by: Kai Wang, et al.
Published: (2021-01-01)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
by: Farnier Michel, et al.
Published: (2011-11-01)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
by: Tarantino N, et al.
Published: (2017-02-01)

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study
by: Lin Zhu, et al.
Published: (2020-03-01)

The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species
by: Al-Habsi, Aziz
Published: (2014)

Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis
by: Lise Van Wyngene, et al.
Published: (2020-02-01)

Étude des fibrates en tant qu'agents stimulateurs de la synthèse des cétones, des substrats énergétiques pour le cerveau vieillissant
by: Tremblay-Mercier, Jennifer
Published: (2008)

Clifford Fibrations and Possible Kinematics
by: Alan S. McRae
Published: (2009-07-01)

Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
by: Marcelo Antonio de Oliveira, et al.

Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease
by: Margaret E. Brousseau, et al.
Published: (2004-10-01)

Guías para el tratamiento de la dislipidemia en pacientes con VIH/SIDA que reciben TARGA
by: Benhard Hasbum, et al.
Published: (2005-07-01)

Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005
by: Myung Ha Lee, et al.
Published: (2012-02-01)

Fibrane the reduced derivative of fenofibrate
by: Amanda E. Kotheimer, et al.
Published: (2020-01-01)

Farmacologia do fibratos Pharmacology of fibrates
by: Hermes Toros Xavier
Published: (2005-10-01)

Effet des fibrates sur la synthèse périphérique et le métabolisme hépatique de la bilirubine, un endobiotique aux propriétés anti-oxydantes et athéro-protectrice
by: El Husseini, Diala
Published: (2009)

Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
by: Jozić Tanja L., et al.
Published: (2014-01-01)

Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence
by: Keshav Kumar Gupta, et al.
Published: (2018-12-01)

A UK general practice population cohort study investigating the association between lipid lowering drugs and 30-day mortality following medically attended acute respiratory illness
by: Roshni Joshi, et al.
Published: (2016-04-01)

A homologia de uma fibração
by: Pagotto, Pablo Gonzalez [UNESP]
Published: (2016)

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention
by: Zhou Yu-Hao, et al.
Published: (2013-01-01)

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
by: Tenenbaum Alexander, et al.
Published: (2012-10-01)

Fibrations de Lefschetz Réelles
by: Salepci, Nermin
Published: (2007)

Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis
by: Roberta Gonçalves Marangoni, et al.
Published: (2011-01-01)

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
by: Michel Farnier, et al.
Published: (2008-12-01)

Lipid Profile Abnormalities in Newly Diagnosed Primary Hypothyroidism in a Tertiary Care Centre of Western Nepal: A Descriptive Cross-sectional Study
by: Prabin Khatri, et al.
Published: (2021-08-01)

Nutrigenetic Contributions to Dyslipidemia: A Focus on Physiologically Relevant Pathways of Lipid and Lipoprotein Metabolism
by: Bridget A. Hannon, et al.
Published: (2018-10-01)

Associations of Youth Weight Status Categories and Cholesterol Levels: Analysis of Data from the National Health and Nutrition Examination Survey
by: Metcalf, Sandra
Published: (2012)

Problème de centre tangentiel et problème de monodromie pour certains Hamiltoniens non-génériques
by: Pontigo Herrera, Jessie Diana
Published: (2016)

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
by: Tenenbaum Alexander, et al.
Published: (2012-11-01)

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
by: I. V. Shirinskiy, et al.
Published: (2012-05-01)

On homotopically equivalent relations for fiber bundles
by: Suliman Dawood, et al.
Published: (2013-10-01)

Anti-atherogenic effects of fibrates in type 2 diabetes
by: Barter Philip
Published: (2001-09-01)

Supersymmetry and the Hopf fibration
by: Simon Davis
Published: (2012-10-01)

Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study
by: Amanda J. Berberich, et al.
Published: (2021-09-01)

Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy
by: Patricia Viganó Contri, et al.
Published: (2011-01-01)